Wogonin is a lipid of Polyketides (PK) class. Wogonin is associated with abnormalities such as Hyperlipidemia, Atherosclerosis, Inflammatory disorder, Dermatitis, Atopic and Ischemia. The involved functions are known as Inflammation, Regulation, luciferase activity, store-operated calcium entry and Transcriptional Activation. Wogonin often locates in Cytoplasmic matrix, Pore, Membrane, Protoplasm and Mitochondria. The associated genes with Wogonin are SGK1 gene, ORAI1 gene, STIM1 gene, P4HTM gene and BCL2 gene.
To understand associated biological information of Wogonin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Wogonin is suspected in Ischemia, Hyperlipidemia, Atherosclerosis, Inflammatory disorder, Dermatitis, Atopic and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Wogonin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Qu JT et al. | Vasodilatory Effect of Wogonin on the Rat Aorta and Its Mechanism Study. | 2015 | Biol. Pharm. Bull. | pmid:26632179 |
Xiao W et al. | Wogonin Inhibits Tumor-derived Regulatory Molecules by Suppressing STAT3 Signaling to Promote Tumor Immunity. | 2015 | J. Immunother. | pmid:25962106 |
Huang Y et al. | Wogonin inhibits LPS-induced vascular permeability via suppressing MLCK/MLC pathway. | 2015 | Vascul. Pharmacol. | pmid:25956732 |
Wang W et al. | Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro. | 2015 | Inflamm. Res. | pmid:25917044 |
Hu C et al. | Wogonin induces apoptosis and endoplasmic reticulum stress in HL-60 leukemia cells through inhibition of the PI3K-AKT signaling pathway. | 2015 | Oncol. Rep. | pmid:25846394 |
Persson C | Drug-induced death of eosinophils. Promises and pitfalls. | 2015 | Am. J. Respir. Crit. Care Med. | pmid:25767918 |
Ge W et al. | Wogonin Induced Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Human Malignant Neuroblastoma Cells Via IRE1α-Dependent Pathway. | 2015 | J. Mol. Neurosci. | pmid:25740014 |
Tan CX et al. | Activities of wogonin analogs and other flavones against Flavobacterium columnare. | 2015 | Chem. Biodivers. | pmid:25676507 |
Zhu Y and Wang J | Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease. | 2015 | Neurol. Sci. | pmid:25596147 |
Yeh CH et al. | Protective effect of wogonin on proinflammatory cytokine generation via Jak1/3-STAT1/3 pathway in lipopolysaccharide stimulated BV2 microglial cells. | 2015 | Toxicol Ind Health | pmid:23592745 |